Status:
RECRUITING
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Lead Sponsor:
Stanford University
Conditions:
Carcinomas (Including Squamous Cell and Adenocarcinoma)
Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to measure the levels of serum proteins and other biomarkers in cancer patients and in patients suspected of having cancer. We believe that some of these markers may be us...
Detailed Description
This is a blood serum collection study at Stanford University for patients with cancer at a variety of disease sites. The purpose of this study is to collect and store blood serum from patients before...
Eligibility Criteria
Inclusion
- Age \> or = 18; for the samples collected under the NIH grant, no subjects below the age of 20 will be enrolled.
- Prior diagnosis of cancer or suspected of having cancer
- Karnofsky performance status of greater than 70
- Standard pretreatment evaluation
- Signed Stanford University Human Subjects Committee consent
Exclusion
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2032
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00349830
Start Date
January 1 2002
End Date
January 1 2032
Last Update
January 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305